mechanism that could explain how PKA might be acti-1D). Immunoblot analysis of the same fractions with vated in cells treated with these inducers.
antibodies to PKAr and PKAc showed that while PKAr We now demonstrate that the PKA catalytic subunit was present only in the fractions where PKA could be (PKAc), but not the PKA regulatory subunit (PKAr), binds activated by cAMP (fractions 19-24) , PKAc was present IB proteins and is associated with the NF-B-IB comboth in fractions containing PKAr (fractions 19-24) and plex. PKAc interacts with IB-␣ and IB-␤ through sewith NF-B-IB complexes (fractions 13-18) ( Figure 1D ). quences from the N terminus of the protein, and this
As previously seen with PKAc that copurified with IB-␤ interaction inhibits the catalytic activity of PKAc. Stimu-( Figure 1B) , the PKAc present in the NF-B-IB fractions lation of cells with inducers of NF-B activity, such as could not be activated by cAMP. To prove that the PKAc LPS, that do not alter the levels of intracellular cAMP, detected in the NF-B-IB fractions was not intrinsically leads to degradation of IB proteins and the consequent defective, we carried out a denaturation-renaturation activation of IB-bound PKAc. Thus, this pathway repreassay for PKA from a purified NF-B-IB-PKAc-consents a novel mechanism by which a portion of PKA in taining fraction (fraction 16) that contained PKAc but cells is regulated in a cAMP-independent manner. The did not exhibit PKA activity (Figures 1D and 1EI) (Hager active PKAc then phosphorylates NF-B p65 at the PKA and Burgess, 1980) . Protein kinase activity was detected consensus site in the Rel domain and leads to a dramatic from the slice corresponding to ‫54-24ف‬ kDa, which is increase in the transcriptional activity of NF-B. Specific around the expected molecular weight of PKAc (Figure inhibition of PKA activity in cells stimulated with in-1EII), demonstrating that association with NF-B-IBducers of NF-B potently inhibits transcriptional ac-␣/␤ complexes inactives PKAc. tivation by NF-B, but not its nuclear translocation or binding to DNA. Therefore, our studies reveal novel mechanisms for regulating the transcriptional activity of PKAc Associates with IB-␣ and IB-␤ NF-B and the activity of a portion of PKA in a cAMPin NF-B-IB Complexes independent manner.
To further examine the association of IB proteins with PKAc and PKAr, we generated constructs by fusing IB-␣ and IB-␤ to glutathione S-transferase and exResults pressed the recombinant fusion proteins in bacteria (Figure 2AI) . We then mixed the purified GST-IB proteins The PKA Catalytic Subunit Copurifies with IB-␤ with 35 S-labeled PKAc, PKAr, and NF-B p65, made by During the purification of IB-␤ protein from rabbit lung in vitro translation in rabbit reticulocyte lysates (Figure cytosol ( Figure 1A ), we noticed a 42 kDa protein that 2AII). After a short incubation, the GST proteins were copurified with IB-␤ ( Figure 1B ) (Thompson et al., 1995) .
precipitated by binding to glutathione-agarose beads Sequencing of this 42 kDa polypeptide showed that it and were washed extensively, and the bound proteins was the ␣ isoform of the catalytic subunit of cyclic AMPwere analyzed by SDS-PAGE, followed by fluorography dependent protein kinase (PKAc ␣) ( Figure 1C ) (Scott, ( Figure 2AIII ). As expected, only p65 and PKAc, but not 1991; Francis and Corbin, 1994) . Because the pIs of PKAr, were bound to the IB proteins. IB-␤ and PKAc are markedly different (4.5 versus 8.6),
We then wanted to determine whether the interaction the coelution of these proteins on ion exchange columns between PKAc and IB-␣/IB-␤ could be observed when strongly suggested that they were associated with each the various proteins were coexpressed in cells. We other. However, to our surprise, we did not observe any therefore cotransfected into COS-1 cells cDNAs encodpolypeptide between ‫25ف‬ and 55 kDa, corresponding ing NF-B p65 and IB-␣ or IB-␤, along with a cDNA to the regulatory subunit of PKA ( Figure 1B) (Scott, 1991;  encoding PKAc, tagged with an epitope from influenza Francis and Corbin, 1994) . The absence of PKAr in these virus. Following transfection, the cells were lysed and preparations was also verified by immunoblotting (data immunoprecipitations were performed with antibodies not shown). Since the activity of PKAc is normally inhibagainst IB-␣, IB-␤, and p65 ( Figure 2B ). The immunoited through its association with PKAr (Scott, 1991; Fran- precipitates were fractionated by SDS-PAGE and immucis and Corbin, 1994), we wanted to determine if the noblotted with an antibody against the flu epitope. In IB-␤-associated PKAc was catalytically active. We all cases, the flu-tagged PKAc could be precipitated, therefore tested the purified IB-␤ fractions containing indicating that it was bound to both NF-B-IB-␣ and PKAc for kinase activity, using the phosphorylation of NF-B-IB-␤ complexes ( Figure 2B ). a fluorescent kempeptide as an assay (see Experimental
The results presented above indicated that both in Procedures), but we could not detect any PKA activity vitro and in transfected cells, PKAc could associate with in these fractions, even in the presence of cAMP (data IB-␣ and IB-␤. To determine whether PKAc was a not shown). This suggested that association of PKAc component of both NF-B-IB-␣ and NF-B-IB-␤ comwith IB-␤ caused inhibition of PKA catalytic activity.
plexes in vivo, we examined the composition of NFTo determine whether PKAc was also present in earlier B-IB complexes in cells, using immunoprecipitation fractions from the purification of NF-B-IB, we chroand immunoblotting techniques. We began by immunomatographed fractions from Sephacryl S-200 (step 4) precipitating NF-B-IB complexes from 70Z/3 and Jur-( Figure 1A ), that were enriched for NF-B-IB comkat cell extracts, using antibodies against NF-B p65. plexes, on a Mono Q column. Assaying the fractions The immunoprecipitates were fractionated by SDSboth for PKA activity in the presence of cAMP and for PAGE and immunoblotted with an antibody directed NF-B activity after deoxycholate (DOC) treatment indiagainst the catalytic subunit of PKA. PKAc was very cated that NF-B-IB complexes and the PKA holoenzyme (R 2 C 2 ) could be separated from one another (Figure efficiently coimmunoprecipitated with p65, suggesting The purification scheme used for purifying IB-␤ from rabbit lung cytosol is shown (Thompson et al., 1995) . (B) A silver-stained gel of the peak fraction of purified IB-␤ from the Superose 12 column (see Experimental Procedures).
(C) The protein sequence of the 42 kDa copurifying band reveals that it is the ␣ isoform of the catalytic subunit of PKA. The three isoforms of PKAc, although highly homologous, have some key differences (shown in bold) that allow them to be distinguished from one another. (X) indicates amino acids that could not be unequivocally assigned by protein sequencing.
(D) The Sephacryl-S200 fraction (step 4 in Figure 1A ) that contains partially purified NF-B-IB complex was chromatographed on a FPLC MonoQ column, and the bound proteins were eluted with a gradient from 75 mM to 500 mM NaCl (the region of the gradient from 100 mM to 400 mM NaCl is shown). The fractions containing protein (fractions 10-26) were assayed for NF-B DNA-binding activity after DOC/NP-40 treatment, PKA activity with and without cAMP, and immunoblot analyses with antibodies to the catalytic subunit of PKA, the regulatory subunit of PKA, IB-␣, and IB-␤. The cAMP-induced PKA activity was seen in fractions 19-24, fractions that also contained the PKAc and PKAr subunits. The NF-B-IB complex containing fractions 12-18 does not contain PKAr but does have PKAc.
(E) (I): Fraction 16 contains DOC-induced NF-B activity but no cAMP-induced PKA activity, in contrast to fraction 22, which does not contain NF-B activity but has cAMP-induced PKA activity. (II): To determine whether the PKAc protein seen on immunoblots of fraction 16 was active, a denaturation-renaturation assay for PKA activity was performed on 300 l of this fraction (Hager and Burgess, 1980) . PKA activity was only detected from the slice around 42-45 kDa (slice 5). The photograph of the agarose gel used for the fluorescent kempeptide assay is on the left, while the quantitation of the assay is on the right.
that it was associated with NF-B-IB complexes (Figwith antibodies against IB-␣ or IB-␤ and used immuure 2C, lanes 1 and 3). Boiling the extracts before immunoblotting to examine whether PKAc was present in noprecipitation resulted in the loss of coimmunoprecipiboth immunoprecipitates ( Figure 2E ). Again, the results tating PKAc, suggesting that it was bound to NF-B-IB indicated that PKAc could be immunoprecipitated with complexes by noncovalent interactions ( Figure 2C , both NF-B-IB-␣ and NF-B-IB-␤ complexes ( Figure  lanes 2 and 4) . We then wanted to determine whether 2E, upper panel, lanes 3 and 4). If a parallel blot was IB-␣, IB-␤, or both IBs could be coprecipitated with probed with the PKAr antibody, the results indicated PKAc. Therefore, we carried out immunoprecipitations that PKAr was only coprecipitated with PKAc ( The lack of PKA activity in the purified IB/PKAc fracof PKAc in both immunoprecipitates ( Figure 2D , lanes tions ( Figure 1A and data not shown) and in purified NF-7 and 8). Therefore, this result demonstrated that PKAc B-IB-PKAc complexes ( Figure 1D ) suggested that the is present in both NF-B-IB-␣ and NF-B-IB-␤ complexes. Finally, we carried out immunoprecipitations binding of IB to PKAc inhibits the enzymatic activity Immunoprecipitations were then carried out on the extracts using the indicated antibodies. After extensive washing of the PAS immunoprecipitates, the bound proteins were eluted by boiling in SDS sample buffer and fractionated on SDS-PAGE, followed by immunoblotting with anti-HA antibodies.
(C) Immunoprecipitations were carried out using antibodies against NF-B p65, from cytosolic extracts of 70Z/3 and Jurkat cells (lanes 1 and 3). Identical immunoprecipitations were carried out on samples that had been boiled with SDS and neutralized with Triton X-100 before adding the immunoprecipitating antibody (lanes 2 and 4). The immunoprecipitates were fractionated on SDS-PAGE and then immunoblotted with an antibody against PKAc. The absence of PKAc in the boiled samples (lanes 2 and 4) indicated that PKAc was associated with NF-B-IB complexes by noncovalent interactions. (D) Extracts from 70Z/3 cells were immunoprecipitated with antibodies against PKAc and PKAr. The immunoprecipitates were fractionated on 10% SDS-PAGE and analyzed by immunoblotting with antibodies against IB-␣ (lanes 1-3), IB-␤ (lanes 4-6), and PKAc (lanes 7-9). The boiled controls were precipitated with the PKAc antibody. (E) Immunoprecipitations on 70Z/3 cells were carried out as in Figure 2D , with antibodies against p65, IB-␣, IB-␤, and PKAc. The immunoprecipitates were analyzed by immunoblotting after SDS-PAGE, using antibodies against PKAc (upper panel) or PKAr (lower panel). The boiled control was precipitated with IB-␤ antibody.
of PKA. To demonstrate that IB proteins can directly interaction with IBs ( Figure 3BIII ). The three-dimensional structure of PKAc has revealed that the protein inhibit PKA activity, we performed an assay in which increasing amounts of GST-IB-␣, GST-IB-␤, GST, and has a bilobate structure, a smaller lobe made up primarily of sequences from the N terminus (amino acids 40-PKAr were added to a fixed amount of purified PKAc ( Figure 3A ). The results showed that both IB-␣ and 125) and a larger lobe consisting primarily of sequences from the C terminus (amino acids 140-280) (Knighton et IB-␤ were able to inhibit the catalytic activity of the purified PKAc preparation ( Figure 3A) . al., 1991a, 1991b) . The catalytic site of the kinase is localized in a deep cleft between the two lobes. The The catalytic activity of PKAc is inhibited by its regulatory subunit PKAr through a direct masking of the subsmaller N-terminal lobe is primarily used for binding to ATP, while substrate binding is carried out with sestrate binding domain (Francis and Corbin, 1994; Walsh and Van Patten, 1994) . To determine whether IBs were quences from the larger, C-terminal lobe. Therefore, the region of PKAc that appears to be critical for interaction also inhibiting the catalytic activity of PKAc through a similar mechanism, we set up an experiment to map the with IBs is different from the substrate binding region of PKAc that is masked by the regulatory subunit (Franregion in PKAc used for interaction with IB. We tested the ability of GST-IB-␣ and GST-IB-␤ proteins to intercis and Corbin, 1994) . Hence, the lack of PKA activity in IB-PKAc complexes ( Figure 1A ) is possibly due to act with different 35 S-labeled deletions of PKAc ( Figures  3BI and 3BII ). The results of the pull-down experiment the masking of the ATP-binding domain of PKAc.
If the interaction of IB with PKAc is confined to the indicated that sequences toward the N terminus of PKAc (minimally, from amino acids 46-76) were critical for N-terminal ATP-binding domain, it might leave the C-ter- (A) Activity of PKA was measured by using the fluorescent kempeptide assay system (see Experimental Procedures). PKA activity was determined from the ratio of phosphorylated peptide to total peptide, by quantitating the amount of each peptide after scanning photographs of the agarose gels. The PKAc and the PKAr used were purified proteins from bovine brain. The purified GST-IB proteins were the same as described earlier (Figure 2A) . In each case, 10 ng of PKAc was used, while the amount of GST-IB-␣, GST-IB-␤, GST, and PKAr varied from 20 ng to 80 ng. (B) (I): Deletions from the C terminus of PKAc were made by truncating the plasmid containing the cDNA at various sites and in vitro translating these templates. (II): The proteins truncated from the N terminus of PKAc were generated by subcloning these smaller proteins into pCDNA3, followed by their expression in vitro in reticulocyte lysates. The amount of lysates added to each assay contained approximately equal amounts of the truncated PKAc proteins, as determined by analyzing the proteins on a 17.5% SDS-PAGE. (III): The proteins associating with the GST-IB proteins were precipitated by using glutathione-agarose and analyzed by SDS-PAGE and fluorography. minal substrate binding domain of PKAc partially unStimulation with NF-B Inducers Activates PKA without Altering cAMP Levels masked. Since we knew that PKAr is not a component of the NF-B-IB complexes, it appeared likely that this Because binding of PKA to IB inhibits kinase activity, we assumed that the removal of IB should activate the region of PKAc interacts with either p50 or p65, since they both contain consensus PKA phosphorylation sites bound PKA. Stimulation of cells with inducers of NF-B activity, such as LPS, results in the phosphorylation and and therefore can act as substrates (Mosialos and Gilmore, 1992) . To test whether PKAc displays any preferdegradation of IB-␣ and IB-␤ proteins (Thompson et al., 1995; Baldwin, 1996) . Therefore, we wanted to test ence between p50 and p65, we produced a GST-PKAc protein and mixed it with 35 S-labeled, in vitro translated whether the degradation of IBs correlates with the activation of PKA in LPS-stimulated cells. We stimulated p50, p65, and PKAr proteins ( Figure 3C) . Surprisingly, precipitation of complexed proteins with glutathione-70Z/3 pre-B cells with LPS for up to 2 hr, a period in which the majority of IB-␣ and IB-␤ is degraded (Figagarose indicated that GST-PKAc forms a stable complex with only p65, and not p50. To further localize the ure 4A) (Thompson et al., 1995; SuYang et al., 1996) . Assaying the extracts for PKA activity revealed that PKA sequences on PKAc that interact with p65, we used a truncated PKAc that contained sequences from the C is activated in these cells in a manner that correlates with the degradation of IBs ( Figure 4B ). As a control, terminus of the protein (amino acids 159-350) for the pull-down experiment and confirmed that the C-terminal we used forskolin, which does not affect IB ( Figure  4A ) but activates PKA by dissociating the PKA R2C2 substrate binding domain of PKAc binds to p65 (data not shown). These interaction experiments therefore complexes through elevation of cAMP levels ( Figure 4B ) (Francis and Corbin, 1994; Walsh and Van Patten, 1994 ). suggest a model in which the N-terminal ATP-binding domain of PKAc binds to IB, while the C-terminal region
To rule out the possibility that activation of PKA in LPStreated cells is due to an increase in cellular levels of establishes interactions with the substrate p65 protein.
Dual sites of interaction might thus allow PKAc to bind cAMP, we measured the level of cAMP in cell extracts using a Biotrak enzyme immunoassay kit (Amersham) stably and avidly to the NF-B-IB complex. (B) PKA activity was measured from the same samples as (A), using (A) 70Z/3 pre-B cells were treated with 10 g/ml LPS or 20 M the fluorescent kempeptide assay. forskolin for the indicated periods. Cytosolic and nuclear extracts (C) Immunoprecipitations were carried out with antibodies against were prepared, and the nuclear extracts were used to examine NF-NF-B p65, from extracts of cells treated with LPS or dibutyryl B DNA binding in EMSA, whereas the cytosolic extract was used cAMP, with or without calapain inhibitor I, as shown in (A). The to perform immunoblots with antibodies to IB-␣ and IB-␤.
immunoprecipitates were analyzed on SDS-PAGE and immunoblot-(B) Total cell extracts from 70Z/3 cells, stimulated as in (A) and made ted with an antibody against PKAc. in parallel, were used to determine the activity of PKA using the fluorescent kempeptide assay. The mean values and standard deviations are shown; at least three independent experiments were done IB-␤ (Verma et al., 1995; Baldwin, 1996) . Pretreatment tion of phosphorylated IBs in stimulated cells (Verma et al., 1995; Baldwin, 1996) . We treated 70Z/3 cells with LPS or dibutyryl cAMP, with or without pretreatment with calpain inhibitor I. The cellular extracts were then ( Figure 4C ). As expected, cells stimulated with forskolin showed an ‫-03ف‬fold increase in cellular cAMP levels.
immunoblotted to determine the levels of IB-␣ and IB-␤ proteins ( Figure 5A ) and assayed for PKA activity In contrast, cells stimulated with LPS demonstrated no significant change in cAMP levels. Therefore, the in-( Figure 5B ). We also carried out immunoprecipitations with the p65 antibody, followed by immunoblotting with crease in PKA activity in LPS-treated cells was not dependent on changes in cAMP levels.
the PKAc antibody to determine the amount of PKA that remained associated with NF-B-IB complexes in these stimulated cells ( Figure 5C ). The results showed Proteasome Inhibitors Block LPS-Dependent, but Not cAMP-Dependent, Activation of PKA that treatment of cells with both LPS and dibutyryl cAMP, an analog of cAMP, activated PKA ( Figure 5B ); To prove that activation of PKA in LPS-treated cells is the result of degradation of IB-␣ and IB-␤, we used however, only LPS treatment caused the degradation of IB-␣ and IB-␤ ( Figure 5A ). Pretreatment of cells calpain inhibitor I to block signal-induced IB degradation. It has been demonstrated previously that treatment with calpain inhibitor I blocked both IB degradation ( Figure 5A , lane 3) and PKA activation ( Figure 5B ) in of cells with inducers of NF-B activity (e.g., LPS) leads to the phosphorylation and degradation of IB-␣ and LPS-stimulated cells, but did not affect activation of Figure 6 . Inhibition of NF-B Activation by Interfering with PKA (A) Jurkat cells were transfected with the pBIIx luc, an NF-B-dependent reporter construct, using lipofectamine reagent (GIBCO-BRL). Twenty-four hours after transfection the cells were treated with PMA/PHA, with or without H-89 or ML-7, at the indicated concentrations. The cells were then lysed, and the total cell extracts were used both to assay for B-specific DNA binding and for luciferase activity.
(B) Hela cells transfected with pBIIx luc, were used for permeabilization. Following permeabilization with the TransPort reagent (GIBCO-BRL), the inhibitory PKI peptide and the control peptide (which inhibits casein kinase II autophosphorylation) were added to the cells. After allowing the peptides to enter, cells were treated with PMA/PHA for 4 hr, after which they were harvested and lysed and the activity of luciferase was determined.
(C) A schematic diagram of the PKAc protein with the mutation at lysine 73 into methionine is shown.
(D) Jurkat cells were transfected with pBIIx luc, alone or with PKAc, wild-type or the mutant. Twenty-four hours after transfection, the cells were stimulated with PMA/PHA, and the expression of the luciferase reporter was quantitated.
PKA in cells treated with dibutyryl cAMP (Figures 5A construct, pBIIx luc, as an assay. We observed dramatic inhibition of PMA/PHA-induced, NF-B-dependent tranand 5B). In all cases, the activation of PKA by LPS correlated with the loss of PKAc in p65 immunoprecipitates scription in the presence of 10 M H-89 ( Figure 6AII ), a concentration that does not affect DNA binding by NF-( Figure 5C, lane 3) . However, in LPS-stimulated cells pretreated with calpain inhibitor I, PKAc could still be B ( Figure 6AI , lane 4). In contrast, ML-7, when used coimmunoprecipitated with p65 ( Figure 5C , lanes 4 and at up to 40 M, had little effect on NF-B-dependent 5). Therefore, the degradation of IB proteins in LPStranscription ( Figure 6AII ). This experiment provides stimulated cells leads to the release and activation of strong evidence for the involvement of PKA in modulatthe associated PKAc.
ing transcriptional activation by NF-B without affecting DNA binding by NF-B. We next used the specific PKA inhibitory peptide, PKI Inhibition of NF-B Activation (amino acids 6-22) amide, to examine the role of PKA upon Interfering with PKA in NF-B-dependent transcription ( Figure 6B ). PKI is a To elucidate the possible role of PKA-mediated phos-16 aa peptide that contains a PKA pseudosubstrate phorylation on NF-B function, we used three different sequence and specifically inhibits PKAc by binding to approaches to specifically inhibit PKA activity in cells.
the substrate binding site (K i of ‫7.1ف‬ nM). To allow the We first used the isoquinoline-sulfonamide derivative, peptide to enter the cell, we permeabilized the cells with H-89, which is one of the most potent inhibitors of PKA the TransPort cell permeabilization kit (GIBCO-BRL), (Ki [inhibition constant] of ‫840.0ف‬ mM). As a control, we which does not lead to a significant loss of cytosolic used ML-7, another inhibitor that is specific for myosin components. Hela cells transfected with the NF-Blight chain kinase. We tested the effect of the two inhibidependent luciferase reporter construct were permetors on LPS-induced activation of NF-B and found that abilized 24 hr after transfection and were treated with both inhibitors had little effect on the NF-B DNA-bindeither the PKI inhibitory peptide or a control peptide, ing complex ( Figure 6AI, lanes 3-5) . We then tested the which competitively inhibits casein kinase II autophoseffect of these inhibitors on NF-B-dependent transcription, using the expression of luciferase from a reporter phorylation. After allowing the peptides to enter, the cells were stimulated with PMA/PHA for 4 hr and luciferwere stimulated with LPS. We therefore metabolically labeled unstimulated and LPS-stimulated 70Z/3 cells ase activity was assessed. Although permeabilization with 32 Pi and immunoprecipitated labeled proteins using itself caused a slight decrease in the level of reporter the p65 antibody. A number of 32 P-labeled proteins were gene expression, the inclusion of the PKI peptide, but seen, including a protein around 65 kDa ( Figure 7B , lane not the control peptide, caused nearly complete inhibi-2), and we confirmed that this 65 kDa protein was p65 tion (Ͼ90%) of reporter gene expression ( Figure 6B ).
by reimmunoprecipitating with the p65 antibody ( Figure  Finally, we generated a mutant, catalytically inactive 7B, lane 4). We then used the dual immunoprecipitation form of PKAc by altering lysine 73 in PKAc to a methiotechnique to examine the effect of inhibiting IB degranine (K73M) ( Figure 6C) . A similar change to a conserved dation on the inducible phosphorylation of p65. We lysine has been demonstrated to inactivate other kitreated 32 P-labeled cells with either PDTC (an antioxidant nases (Taylor et al., 1990; Scott, 1991) . We verified that that prevents signal-induced phosphorylation of IB), this mutation results in a catalytically inactive form of calpain inhibitor I (which blocks the degradation of in-PKA by expressing it in COS cells and assaying PKA ducibly phosphorylated IB), or H-89 (which inhibits activity (data not shown). We then tested the ability of PKA). The results of the labeling experiments indicate this mutated kinase to interfere with NF-B function that both PDTC and calpain inhibitor I completely block by cotransfecting it with the B-dependent luciferase the inducible phosphorylation of p65 ( Figure 7B , lanes reporter construct. We expected the transfected mutant 5 and 6), whereas H-89 inhibits such phosphorylation PKAc to interfere with PKAc-dependent activation of ( Figure 7B , lane 7). Therefore, the inducible phosphory-NF-B, and, as shown in Figure 6D , introduction of this lation of p65 upon LPS treatment appears to be depenmutant form into cells caused a dramatic decrease in dent on the degradation of IB and the activity of PKA. the amount of transcription from the reporter construct
To further localize the site of phosphorylation on p65 in when cells were stimulated with PMA/PHA. In contrast, LPS-stimulated cells, we isolated the inducibly phostransfection of wild-type PKAc along with the reporter phorylated p65 protein and digested it with either trypconstruct exhibited marginal effects on PMA/PHAsin, chymotrypsin, LysC, or CNBr ( Figure 7C ). The phosinduced transcription ( Figure 6C ). This result further phopeptides were then separated on a high-resolution strengthens the hypothesis that phosphorylation by PKA Tris-tricine gel system (Schagger and von Jagow, 1987). enhances transcriptional activation mediated by NF-B.
The sizes of the phosphopeptides obtained ‫9ف(‬ kDa for Since neither activation of PKA alone ( Figure 4A) nor LysC, ‫4.3ف‬ kDa for chymotrypsin, ‫5.1ف‬ kDa for CNBr, inhibition of PKA by H-89 ( Figure 6A ) affects the nuclear and ‫5.0ف‬ kDa for trypsin), when compared to predicted translocation and DNA binding by NF-B, the role of peptides based on the sequence, indicated that they PKA appears to be a modulator of transcriptional activity most likely include Ser 276 of the p65 protein (Figure of NF-B entering the nucleus. 7C). These results therefore suggest that the inducible phosphorylation of p65 in LPS-stimulated cells occurs on Ser 276 in the consensus PKA phosphorylation site.
Transcriptional Activity of NF-B Is Stimulated
We then generated a site-directed mutant of p65 in by Phosphorylation of p65 by PKA which the serine 276 was altered to a nonphosphorylat-A possible mechanism to explain the effect of PKA on able alanine residue (S276A) ( Figure 7D ). We tested the transcription by NF-B might be the direct phosphorylaability of this protein to transactivate the B-dependent tion of NF-B subunits by PKAc at the consensus site for reporter construct upon transfection into COS cells. Im-PKA phosphorylation. Although almost all Rel proteins munoblots of the transfected cells indicated that both have a conserved PKA phosphorylation site (Mosialos the wild-type and mutant p65 proteins were expressed and Gilmore, 1992), previous studies have shown that in equivalent amounts (data not shown). However, there only inducibly phosphorylated p65 and p105 can be was a marked difference in the ability of the two p65 detected in stimulated Hela and Jurkat cells (Naumann forms to transactivate, as measured by the expression and Scheidereit, 1994; Neumann et al., 1995) . Since of luciferase from a reporter construct ( Figure 7D ). To PKAc is directly associated with IB-␣ and IB-␤, which examine the effect of PKA on transactivation by NF-B, in turn interacts only with p65, it is possible that degradawe cotransfected Jurkat cells with wild-type or K73H tion of IB proteins allows PKA to specifically phosphormutant PKAc and wild-type or S276A mutant p65, and ylate p65. We have also found that PKAc interacts with measured B-dependent luciferase activity ( Figure 7E ). only p65, and not p50, through its substrate binding Transfection of wild-type or mutant PKAc alone had no region ( Figure 3C and our unpublished data), and thereeffect on NF-B. Transfection of wild-type and mutant fore, degradation of IBs should lead to a preferential p65 alone resulted in low levels of expression of luciferphosphorylation of the bound p65 protein.
ase, as seen earlier ( Figure 7D ). Cotransfection of PKAc To directly demonstrate that PKAc can phosphorylate with p65 led to a dramatic increase in the expression p65, we used a truncated form of p65 (amino acids of the reporter gene, and this increase was not seen if 1-313), which retains the Rel homology domain and the the K73M mutant of PKAc was used ( Figure 7E ). The PKA phosphorylation site, as a substrate for PKA phosreciprocal experiment, in which wild-type PKAc was phorylation. This purified, bacterially expressed p65 protransfected with wild-type and S276A mutant p65, retein was efficiently phosphorylated by purified PKAc vealed the same effect on NF-B-dependent transcrip-( Figure 7A, lane 1) , and the phosphorylation was blocked tion ( Figure 7E ). These results provide compelling eviby the inclusion of the PKA inhibitory peptide, PKI (Fig- dence that phosphorylation of p65 by PKA at serine ure 7A, lane 2). We then wanted to determine whether 276 causes a significant stimulation of transcriptional activity of NF-B. p65 was inducibly phosphorylated by PKA when cells (C) The site for LPS-induced phosphorylation on p65 was mapped using phosphopeptide mapping. The 32 P-labeled proteins from LPSstimulated cells were transferred to nitrocellulose, and after autoradiography, the labeled p65 band was excised and digested with the indicated enzymes and CNBr. The upper band in the trypsin lane probably results from incomplete digestion. (D) The sequence of the PKA phosphorylation site in p65 and the serine residue that is changed to alanine in the mutant are indicated. The mutant protein is not phosphorylated by PKAc in vitro (data not shown). The wild-type and mutant p65 proteins were expressed in Jurkat cells along with the pBIIx luc construct. Twenty-four hours after transfection, the transfected cells were harvested and the expressed luciferase was quantitated. A concentration of 0.5 g p65 was used for transfection in the subsequent assays. (E) Jurkat cells were transfected with 0.5 g of p65 (wild-type or mutant) and 1 g of PKAc (wild-type or mutant), along with the pBIIx luc reporter construct. Cells were harvested for luciferase assay 24 hr after transfection. (F) Jurkat cells were transfected with p65 wild-type and mutant, along with the pBIIx luc, similar to that in (E). Twenty-four hours after transfection, the indicated cells were treated with 50 M dibutyryl cAMP for 2 hr, before harvesting all the samples to assay luciferase activity.
To test whether this effect of PKA on NF-B activity that IB-associated PKAc is regulated in a cAMP-independent manner. Essentially, this is accomplished by could be seen by costimulating cells with PKA activators such as dibutyryl cAMP, we transfected p65 into Jurkat replacing the regulatory subunit of PKA by IB to form a pool of cytosolic NF-B-IB-PKAc complex, in which cells using the B-dependent luciferase reporter and stimulated them with dibutyryl cAMP ( Figure 7F ). Howthe association between PKAc and NF-B-IB blocks the catalytic activity of PKA. This pool of PKA is insensiever, costimulation with dibutyryl cAMP resulted in only a modest stimulation of the transcriptional activity of tive to changes in levels of intracellular cAMP; instead, treatment of cells with inducers of NF-B activity that NF-B ( Figure 7F ). This suggests that efficient phosphorylation of p65 occurs only when PKAc is a comporesult in the degradation of IB causes the activation of this PKAc. We have also demonstrated that transcripnent of the NF-B-IB complex and, hence, is in close vicinity to the substrate. This also suggests that cAMPtional activity of NF-B can be influenced through phosphorylation by PKA, a finding that brings NF-B into the induced PKA is unlikely to significantly affect the activity of NF-B.
larger group of transcription factors whose activity can be regulated directly by phosphorylation. Well characterized examples include AP-1 and CREB, whose direct Discussion phosphorylation by Jun kinases or PKA, respectively, helps to determine whether the transcription factor is The results presented in this paper describe novel mechanisms by which the activity of both PKA and NF-B is able to activate transcription (Karin, 1995; SassoneCorsi, 1995) . Therefore, in the case of NF-B, it appears regulated. The most surprising finding in this work is that its activity is regulated at two levels: (1) its release time when the Drosophila IB homolog, Cactus, is degraded (Whalen and Steward, 1993 ; Gillespie and Wasfrom cytosolic complexes with IB, and (2) its phosphorylation at a specific site by PKA. Such a layering of serman, 1994). The knowledge that PKA might be activated during dorso-ventral patterning also raises regulatory mechanisms might help cells to more finely tune the expression of genes regulated by NF-B.
questions about the role that active PKA might play in regulating the activity of other developmental regulators We also show that inhibition of PKA activity in cells treated with inducers of NF-B activity does not signifisuch as the hedgehog protein.
It remains to be determined whether all NF-B-IB cantly affect the dissociation of NF-B-IB complexes, the translocation of NF-B to the nucleus, or the binding complexes contain PKAc, or whether a fraction of the cytosolic NF-B-IB complexes can exist without PKAc. of NF-B to DNA. Instead, what is dramatically affected is the transcriptional activity of NF-B, as determined
The lack of associated PKAc in a fraction of the complexes could have a significant regulatory impact if these by its ability to drive transcription of a B-dependent reporter construct. This effect of PKA is mediated complexes were targeted differently from those containing PKAc, since unphosphorylated NF-B released through the direct phosphorylation of NF-B p65 (Figures 7B and 7C) , since a site-directed mutation at the from such PKAc-deficient NF-B-IB complexes would be less effective transcriptionally. In such a scenario, consensus PKA phosphorylation site in p65 abolishes the dependence of NF-B on PKA for transcriptional the activity of unphosphorylated NF-B might then be regulated by costimulation with inducers that activate activity ( Figure 7F ). We are also struck by the novelty of the IB-PKA interaction, since it appears to involve PKAc through the elevation of cAMP levels, although we have found that cAMP-induced PKA does not signifi-N-terminal sequences of PKAc that comprise the ATPbinding domain (Knighton et al., 1991b; Francis and Cor- cantly affect NF-B activity ( Figure 7F) . However, such a dependence of NF-B activity on costimulation might bin, 1994; Walsh and Van Patten, 1994) . Since no other protein that interacts specifically with this region of allow the cell to use NF-B activity in two ways: (1) unphosphorylated NF-B could bind to B sites and PKAc has been characterized, the structural features used for this interaction remain to be defined (Francis drive low level transcription, or (2) NF-B phosphorylated by PKA could drive transcription at a high level. and Corbin, 1994; Walsh and Van Patten, 1994) . Although theoretically the interaction of IB proteins with In summary, the results presented in this report provide a novel insight into the regulation of two very imporPKAc might allow the binding of the regulatory subunit to the C terminus of PKAc, we have not observed any tant regulatory molecules in the cell, the transcription factor NF-B and the protein kinase PKA. In particular, PKAr in NF-B-IB-PKAc complexes. The lack of PKAr in the NF-B-IB-PKAc complex might be due to steric the discovery of a novel mechanism for regulating PKA, probably the most well studied protein kinase, was factors, or due to the interaction of the C-terminal substrate binding region of PKAc with p65. Therefore, in highly surprising. We believe that the interaction between PKAc and ankyrin repeats might not be confined our proposed model, the degradation of IB leads to the activation of PKAc by unmasking the ATP-binding to IB proteins and might include other regulatory proteins. Identifying other such anchors for PKAc will be domain, and the active PKAc immediately phosphorylates p65, the substrate to which it is already bound.
an important area of investigation in the future. Such a coordinated phosphorylation might be necessary, since in cells where the level of cAMP is unaltered,
Experimental Procedures
free, active PKAr in the cytosol might rapidly inactivate any released PKAc before it can phosphorylate its inPurification of NF-B-IB and IB from Rabbit Lung Cytosol and Sequencing of the 42 kDa Copurifying Polypeptide tended substrate, p65, which is taken up into the nuclear
The purification of IB proteins has been described previously (Fig- import pathway. ure 1A) (Thompson et al., 1995) . The 42 kDa band from the peak The involvement of PKA in the regulation of Rel tranfraction of the Superose 12 column (step 8) was used for internal scription factors has been most intensively studied in sequence analysis ( Figure 1A) , and three tryptic peptides were seDrosophila, where activation of PKA leads to the stimuquenced. The yields of the three PKAc peptides were: T9, 1.5 pmol; lation of transcription by Dorsal (Norris and Manley, T15, 1.2 pmol; and T 32, 1 pmol. The 42 kDa protein appears to stain less efficiently with silver, since the yield of peptides from the 1992). In addition, cotransfection of Dorsal with PKA sequencing reactions indicated that it was present in equimolar leads to enhanced transcription, and the enhancement amounts compared to peptides from IB-␤ (T15-␤, 1.4 pmol; T27-␤, is blocked if a catalytic mutant of PKA is used (Norris 1.6 pmol; T41-␤, 1.5 pmol) (Thompson et al., 1995) . The mean aband Manley, 1992). It has also been reported that Dorsal sorbance of peptide T32 from PKAc (24 amino acids, no Trp) at 214 is multiply phosphorylated concomitant to its entry into nm was 3.5 mAU, compared to peptide T27-␤ from IB-␤ (21 amino the nucleus in the embryo (Whalen and Steward, 1993;  acids, no Trp), which was 3.0 mAU. Because these peptides are of comparable length and devoid of Trp, they are likely to have similar Gillespie and Wasserman, 1994) . Despite these results, molar extinction coefficients. Therefore, their equal absorption at a critical role for PKA in the activation of Dorsal has not 214 nm strongly suggests that the proteins from which they were been widely accepted because there was no explanaderived were present in roughly equimolar amounts. tion for how PKA might be activated during the time when Dorsal was activated. Also, the inability to gener- of Dorsal in a cAMP-independent manner during the
